US authorities’s high illness physician informed Reuters the nation might not want AstraZeneca’s vaccine.
The U.S. authorities on Saturday stopped a Baltimore manufacturing plant that ruined 15 million doses of Johnson & Johnson’s COVID-19 vaccine from making the vaccine developed by AstraZeneca Plc, the New York Instances reported.
J&J mentioned in an announcement that it was “assuming full accountability concerning the manufacturing of drug substance for its COVID-19 vaccine on the Emergent BioSolutions Inc. Bayview facility.”
It didn’t specify if it should take over the plant. The corporate didn’t reply to Reuters’ requests for remark for clarification.
The New York Instances reported that AstraZeneca mentioned in an announcement it should work with President Joe Biden’s administration to search out another website. The drugmaker didn’t reply to a request for remark.
The transfer by the U.S. Division of Well being and Human Providers’ will render the Emergent BioSolutions facility solely devoted to creating the Johnson & Johnson single-dose vaccine, and is supposed to keep away from future mix-ups, in response to the newspaper report, which cites two senior federal well being official
The U.S. authorities’s high infectious illness physician informed Reuters the nation might not want AstraZeneca’s vaccine, even when it wins approval.
(Apart from the headline, this story has not been edited by NDTV workers and is printed from a syndicated feed.)
